Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Mechanisms of Pathogenicity of Hypertrophic Cardiomyopathy-Associated Troponin T (TNNT2) Variant R278C+/- During Development.
Shafaattalab S, Li AY, Jayousi F, Maaref Y, Dababneh S, Hamledari H, Baygi DH, Barszczewski T, Ruprai B, Jannati S, Nagalingam R, Cool AM, Langa P, Chiao M, Roston T, Solaro RJ, Sanatani S, Toepfer C, Lindert S, Lange P, Tibbits GF. Shafaattalab S, et al. Among authors: langa p. bioRxiv [Preprint]. 2023 Aug 13:2023.06.06.542948. doi: 10.1101/2023.06.06.542948. bioRxiv. 2023. PMID: 37609317 Free PMC article. Preprint.
Amelioration of Morphological Pathology in Cardiac, Respiratory, and Skeletal Muscles Following Intraosseous Administration of Human Dystrophin Expressing Chimeric (DEC) Cells in Duchenne Muscular Dystrophy Model.
Siemionow M, Budzynska K, Zalants K, Langa P, Brodowska S, Siemionow K, Heydemann A. Siemionow M, et al. Among authors: langa p. Biomedicines. 2024 Mar 6;12(3):586. doi: 10.3390/biomedicines12030586. Biomedicines. 2024. PMID: 38540201 Free PMC article.
Correction: Long-Term Protective Effect of Human Dystrophin Expressing Chimeric (DEC) Cell Therapy on Amelioration of Function of Cardiac, Respiratory and Skeletal Muscles in Duchenne Muscular Dystrophy.
Siemionow M, Langa P, Brodowska S, Kozlowska K, Zalants K, Budzynska K, Heydemann A. Siemionow M, et al. Among authors: langa p. Stem Cell Rev Rep. 2023 Feb;19(2):582-583. doi: 10.1007/s12015-022-10472-3. Stem Cell Rev Rep. 2023. PMID: 36441490 Free PMC article. No abstract available.
Long-Term Biodistribution and Safety of Human Dystrophin Expressing Chimeric Cell Therapy After Systemic-Intraosseous Administration to Duchenne Muscular Dystrophy Model.
Siemionow M, Brodowska S, Langa P, Zalants K, Kozlowska K, Grau-Kazmierczak W, Heydemann A. Siemionow M, et al. Among authors: langa p. Arch Immunol Ther Exp (Warsz). 2022 Aug 17;70(1):20. doi: 10.1007/s00005-022-00656-7. Arch Immunol Ther Exp (Warsz). 2022. PMID: 35978142 Free PMC article.
Long-Term Protective Effect of Human Dystrophin Expressing Chimeric (DEC) Cell Therapy on Amelioration of Function of Cardiac, Respiratory and Skeletal Muscles in Duchenne Muscular Dystrophy.
Siemionow M, Langa P, Brodowska S, Kozlowska K, Zalants K, Budzynska K, Heydemann A. Siemionow M, et al. Among authors: langa p. Stem Cell Rev Rep. 2022 Dec;18(8):2872-2892. doi: 10.1007/s12015-022-10384-2. Epub 2022 May 19. Stem Cell Rev Rep. 2022. PMID: 35590083 Free PMC article.
29 results